If you're wanting to add some ASX 200 shares to your retirement portfolio, then it could be worth considering the two listed below.
Both are high-quality businesses and offer potentially strong returns to investors.
Here's what Goldman Sachs is saying about them:
Image source: Getty Images
CSL Limited (ASX: CSL)
CSL could be a good option for a retirement portfolio. It is one of the world's leading biotherapeutics companies and the owner of a collection of industry-leading therapies. This includes therapies such as Privigen, Hizentra, Idelvion, and Afstyla.
While its shares don't provide the biggest dividend yield today, it could grow strongly over the next decade. So, if income isn't your main focus today, then CSL would be worth considering.
Goldman Sachs thinks it would be a top buy. It believes CSL is now entering a period of more capital-efficient growth and is forecasting a compound annual growth rate of 14% for its earnings per share between FY 2023 and FY 2027.
It is for this reason that Goldman has a buy rating and a $309 price target on its shares.
Woolworths Limited (ASX: WOW)
Another ASX 200 share that Goldman Sachs thinks could be a buy is Woolworths.
It is Australia's largest supermarket chain, as well as the owner of Big W and a growing pet care business.
It could be a good option for a retirement portfolio due to its defensive qualities, strong market position, and positive growth outlook. The latter is being underpinned by its omni-channel advantage and sticky loyalty program.
In addition, Goldman is expecting attractive dividend yields from its shares. It is forecasting yields of 3%, 3.3%, and 3.6%, respectively, over the next three financial years.
Goldman has a conviction buy rating and a $42.40 price target on the company's shares.
